agilon health, inc.
AGL
$96.58
$3.854.15%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.91B | 5.81B | 5.92B | 5.87B | 5.89B |
| Total Other Revenue | 9.12M | 10.24M | 11.24M | 11.97M | 12.32M |
| Total Revenue | 5.92B | 5.82B | 5.93B | 5.89B | 5.90B |
| Cost of Revenue | 5.91B | 5.97B | 6.09B | 5.99B | 6.01B |
| Gross Profit | 13.84M | -145.73M | -160.02M | -107.61M | -104.13M |
| SG&A Expenses | 239.85M | 215.15M | 232.46M | 233.61M | 243.18M |
| Depreciation & Amortization | 28.05M | 28.51M | 28.59M | 28.12M | 26.91M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.17B | 6.21B | 6.35B | 6.25B | 6.28B |
| Operating Income | -254.07M | -389.38M | -421.08M | -369.34M | -374.21M |
| Income Before Tax | -250.57M | -372.46M | -404.10M | -321.21M | -327.70M |
| Income Tax Expenses | 646.00K | 1.08M | 1.25M | 1.68M | 1.43M |
| Earnings from Continuing Operations | -251.22 | -373.54 | -405.35 | -322.90 | -329.12 |
| Earnings from Discontinued Operations | 19.00M | 19.00M | 14.00M | 14.64M | 13.46M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 0.00 | 0.00 |
| Net Income | -232.22M | -354.54M | -391.35M | -308.26M | -315.66M |
| EBIT | -254.07M | -389.38M | -421.08M | -369.34M | -374.21M |
| EBITDA | -229.26M | -364.12M | -395.73M | -341.22M | -347.30M |
| EPS Basic | -14.01 | -21.39 | -23.61 | -18.64 | -19.13 |
| Normalized Basic EPS | -7.37 | -12.25 | -13.65 | -11.83 | -12.20 |
| EPS Diluted | -14.06 | -21.41 | -23.61 | -18.64 | -19.14 |
| Normalized Diluted EPS | -7.40 | -12.25 | -13.65 | -11.83 | -12.20 |
| Average Basic Shares Outstanding | 66.47M | 66.32M | 66.23M | 66.13M | 66.02M |
| Average Diluted Shares Outstanding | 67.04M | 66.38M | 66.23M | 66.13M | 66.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |